Activation of microglial cells by β-amyloid protein and interferon-γ

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature

• Publication date

  1995-04-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/374647A0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

  1994cited by this paper
• Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• The role of pyruvate in neuronal calcium homeostasis. Effects on intracellular calcium pools.

  1994cited by this paper
• Macrophages and inflammation in the central nervous system.

  1993cited by this paper
• A radical hypothesis for neurodegeneration.

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide

  1993cited by this paper
• Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.

  1993cited by this paper
• Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.

  1993cited by this paper
• Neuroprotective role of IL-4 against activated microglia.

  1993cited by this paper
• Inducible nitric oxide synthase activity of cloned murine microglial cells

  1993cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Genetics and molecular advances in Alzheimer's disease

  1993cited by this paper
• Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.

  1992cited by this paper
• β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

  1992cited by this paper
• Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.

  1992cited by this paper
• Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death.

  1992cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Heterotypic and homotypic cellular interactions influencing the growth and differentiation of bipotential oligodendrocyte-type-2 astrocyte progenitors in culture.

  1991cited by this paper
• β-Amyloid and the pathogenesis of alzheimer's disease

  1991cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• GABA accumulating neurons are relatively resistant to chronic hypoxia in vitro: an autoradiographic study.

  1990cited by this paper
• Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

  1988cited by this paper
• Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

  1987cited by this paper

• Related Mechanism of Limonene Improves LPS-Induced Neuroinflammation

  2025cites this paper
• The novel sphingolipids cP1P and P1P attenuate neuroinflammation and enhance S1PR1/Akt/mTOR signaling to mitigate cognitive decline in an Alzheimer’s disease mouse model

  2025cites this paper
• Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

  2025cites this paper
• Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy

  2025cites this paper
• Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions

  2025cites this paper
• Circadian Rhythm, Microglia-Mediated Neuroinflammation, and Alzheimer's Disease.

  2025cites this paper
• Subtle Alterations in Hippocampal Neuronal Activity Coincide With Early Sex‐Specific Differences in Amyloidosis and Microglia in a Pre‐Symptomatic Mouse Model of Alzheimer‐Like Pathology

  2025influential citation
• A cathodic photoelectrochemical dual aptamer-based biosensor for detection of β-amyloid peptide

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• Impact of prior exposures on biomarkers of blast during military tactical training

  2025cites this paper
• Chrysin: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Potential

  2025cites this paper
• Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models

  2025cites this paper
• Bridging Mechanical Properties with Atomic Structures of Polymorphic α‐Synuclein Fibrils by Single‐Molecule Analysis and Molecular Dynamics Simulations

  2025cites this paper
• Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)

  2024cites this paper
• Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management.

  2024cites this paper
• Intracerebral inoculation of healthy non-transgenic rats with a single aliquot of oligomeric amyloid-β (1–42) profoundly and progressively alters brain function throughout life

  2024cites this paper
• Effects of Intravenously Administered Plasma from Exercise-Trained Donors on Microglia and Cytokines in a Transgenic Rat Model of Alzheimer’s Disease

  2024cites this paper
• Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease

  2024cites this paper
• In Vitro Assessment of the Neuroprotective Effects of Pomegranate (Punica granatum L.) Polyphenols Against Tau Phosphorylation, Neuroinflammation, and Oxidative Stress

  2024cites this paper
• The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer's disease.

  2024cites this paper
• Gangliosides as Therapeutic Targets for Neurodegenerative Diseases

  2024cites this paper
• Evaluating the associations between intelligence quotient and multi-tissue proteome from the brain, CSF and plasma

  2024cites this paper
• CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis.

  2024cites this paper
• Mechanistic insights into the role of amyloid-β in innate immunity

  2024cites this paper
• Box–Behnken Design-Based Optimization of Phytochemical Extraction from Diplazium esculentum (Retz.) Sw. Associated with Its Antioxidant and Anti-Alzheimer’s Properties

  2024cites this paper
• Conformational Dynamics of an α-Synuclein Fibril upon Receptor Binding Revealed by Insensitive Nuclei Enhanced by Polarization Transfer-Based Solid-State Nuclear Magnetic Resonance and Cryo-Electron Microscopy.

  2023cites this paper
• Protein amyloid aggregate: Structure and function

  2023cites this paper
• Reduction in GABAB on glia induce Alzheimer's disease related changes.

  2023cites this paper
• Alzheimer’s genes in microglia: a risk worth investigating

  2023cites this paper
• Sensitive dual-mode sensing platform for Amyloid β detection: Combining dual Z-scheme heterojunction enhanced photoelectrochemistry analysis and dual-wavelength ratiometric electrochemiluminescence strategy.

  2023cites this paper
• Long RNA Profiles of Human Brain Extracellular Vesicles Provide New Insights into the Pathogenesis of Alzheimer’s Disease

  2023cites this paper
• Determination of soluble tumor necrosis factor receptor II and secretory immunoglobulin A in saliva of patients with dementia

  2023cites this paper
• Development of small molecules for disrupting pathological amyloid aggregation in neurodegenerative diseases

  2023cites this paper
• : Meta-analysis of neuroinflammation in mild cognitive impairment and Alzheimer’s disease

  2023cites this paper
• Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer’s Disease in AppNL-G-F Mice

  2023cites this paper
• Innate and adaptive glial cell responses in Alzheimer’s disease

  2023cites this paper
• The pollutome-connectome axis: A putative mechanism to explain pollution effects on neurodegeneration.

  2023cites this paper
• siRNA drug delivery across the blood-brain barrier in Alzheimer's Disease.

  2023cites this paper
• Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies

  2023cites this paper
• The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments

  2022cites this paper
• Experimental modelling of Alzheimer’s disease for therapeutic screening

  2022cites this paper
• Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology

  2022cites this paper
• Switchable Multiplex Photoelectrochemical Immunoassay of Aβ42 and Aβ40 Based on a pH-Responsive i-Motif Probe and Pyrene-Based MOF Photocathode.

  2022cites this paper
• Pan HDACi Valproic Acid and Trichostatin A Show Apparently Contrasting Inflammatory Responses in Cultured J774A.1 Macrophages

  2022cites this paper
• Pyroptosis as a candidate therapeutic target for Alzheimer’s disease

  2022cites this paper
• Recent Studies on Protective Effects of Walnuts against Neuroinflammation

  2022cites this paper
• Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease

  2022cites this paper
• Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease

  2022cites this paper
• Plasma amyloid-β40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study.

  2022cites this paper
• The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

  2022cites this paper
• Saikogenin F From Bupleurum smithii Ameliorates Learning and Memory Impairment via Antiinflammation Effect in an Alzheimer’s Disease Mouse Model

  2022cites this paper
• Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.

  2022cites this paper
• The Emergence of Model Systems to Investigate the Link Between Traumatic Brain Injury and Alzheimer’s Disease

  2022cites this paper
• Synapses, Microglia, and Lipids in Alzheimer’s Disease

  2022cites this paper
• Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

  2022cites this paper
• Recruitment of the CoREST transcription repressor complexes by Nerve Growth factor IB-like receptor (Nurr1/NR4A2) mediates silencing of HIV in microglial cells

  2022cites this paper
• On the Potential Therapeutic Roles of Taurine in Autism Spectrum Disorder

  2022cites this paper
• Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis

  2022cites this paper
• Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs

  2022cites this paper
• Protective Signature of IFNγ-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells

  2022cites this paper
• Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases

  2022cites this paper
• Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease

  2022cites this paper
• Neuroinflammation in Low-Level PM2.5-Exposed Rats Illustrated by PET via an Improved Automated Produced [18F]FEPPA: A Feasibility Study

  2022cites this paper
• Peripheral inflammation and neurodegeneration; a potential for therapeutic intervention in Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS)

  2022cites this paper
• Altered gut microbiota correlates with cognitive impairment in Chinese children with Down’s syndrome

  2021cites this paper
• Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease

  2021cites this paper
• Particulate Matter Exposure Exacerbates Amyloid-β Plaque Deposition and Gliosis in APP/PS1 Mice

  2021cites this paper
• Neuroprotective and anti-neuroinflammatory effects of ethanolic extract from leaves and stems of Aster glehni

  2021cites this paper
• Indomethacin Disrupts the Formation of β-Amyloid Plaques via an α2-Macroglobulin-Activating lrp1-Dependent Mechanism

  2021cites this paper
• Anti-inflammatory and neuroprotective effects of astragalin isolated from Aster scaber

  2021cites this paper
• Commentary: Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders

  2021cites this paper
• Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis

  2021cites this paper
• The Nerve Growth Factor IB-like Receptor Nurr1 (NR4A2) Recruits CoREST Transcription Repressor Complexes to Silence HIV Following Proviral Reactivation in Microglial Cells

  2021cites this paper
• Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation

  2021cites this paper
• Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.

  2021cites this paper
• Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease

  2021cites this paper
• Calorie restriction modulates Neuro-immune system differently in young and aged rats.

  2021cites this paper
• Lack of Cathepsin D in the central nervous system results in microglia and astrocyte activation and the accumulation of proteinopathy-related proteins

  2021cites this paper
• GM-CSF induces noninflammatory proliferation of microglia and disturbs electrical neuronal network rhythms in situ

  2020cites this paper
• Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

  2020cites this paper
• Growth differentiation factor 15 protects against the aging‐mediated systemic inflammatory response in humans and mice

  2020cites this paper
• C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation.

  2020cites this paper
• Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection

  2020cites this paper
• Meta-analysis of neuroinflammation in mild cognitive impairment and Alzheimer’s disease

  2020cites this paper
• Seminal plasma promotes decidualization of endometrial stromal fibroblasts in vitro from women with and without inflammatory disorders in a manner dependent on interleukin-11 signaling.

  2020cites this paper
• Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease

  2020cites this paper
• MiR-1202 Exerts Neuroprotective Effects on OGD/R Induced Inflammation in HM Cell by Negatively Regulating Rab1a Involved in TLR4/NF-κB Signaling Pathway

  2020cites this paper
• Effect of combined extracts of aged garlic, ginger, and chili peppers on cognitive performance and brain antioxidant markers in Aβ-induced rats

  2020cites this paper
• Circulating inflammatory cytokine levels correlates with cognitive impairment

  2020cites this paper
• Pathological Links between Traumatic Brain Injury and Dementia: Australian Pre-Clinical Research

  2020cites this paper
• Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses

  2020cites this paper
• Can We Treat Neuroinflammation in Alzheimer’s Disease?

  2020cites this paper
• Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease

  2020cites this paper
• The pathogenesis of age-related macular degeneration is not inflammatory mediated but is instead due to immunosenescence-related failure of tissue repair.

  2020cites this paper
• Rifampicin Suppresses Amyloid-β Accumulation Through Enhancing Autophagy in the Hippocampus of a Lipopolysaccharide-Induced Mouse Model of Cognitive Decline

  2020cites this paper
• Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice

  2020cites this paper
• Anti-Amnesic Effect of Walnut via the Regulation of BBB Function and Neuro-Inflammation in Aβ1-42-Induced Mice

  2020cites this paper
• The effect of insomnia on development of Alzheimer’s disease

  2020cites this paper
• Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation

  2020cites this paper
• Physical exercise in the prevention and treatment of Alzheimer's disease

  2020cites this paper